Canada Pension Plan Investment Board’s Oric Pharmaceuticals ORIC Stock Holding History

Canada Pension Plan Investment Board’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$128K	Buy	+11,800	New	+$107K	﹤0.01%	1651

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Canada Pension Plan Investment Board's ORIC Position: Q2 2026 in Review

Canada Pension Plan Investment Board opened a new position in Oric Pharmaceuticals (ORIC) in Q2 2026: 11,800 shares worth $128K. The stake represents ﹤0.01% of the portfolio and ranks #1651 among its holdings.

180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

Canada Pension Plan Investment Board held 11,800 shares of Oric Pharmaceuticals worth $128K as of Q2 2026.
Oric Pharmaceuticals was a new Canada Pension Plan Investment Board position in Q2 2026.
Oric Pharmaceuticals made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1651 holding.
180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.